2m 2m 2m 2m 2m 2m 2m
Nexien BioPharma (NXEN)
OTC
$0.0001$0.00 (0.00%)
Price as of Jun 01, 2026- $7,077.00Market Cap
- -98.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Nexien BioPharma (NXEN)
$0.0001$0.00 (0.00%)
NXEN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 500 | ||
30-Day Average Volume | 6,866 | ||
1-Week Change | 0.00% | ||
1-Month Change | 0.00% | ||
1-Year Change | -98.95% | ||
3-Year Change | -99.79% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 70.8M | ||
Total Assets | $8,285.00 | ||
Market Cap | $7,077.00 | ||
Enterprise Value | $158,792.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$30,092.00 | ||
Free Cash Flow | -$13,021.00 | ||
EBIT | -$18,663.00 | ||
EBITDA | -$18,663.00 | ||
Net Working Capital | -$450,516.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||